Benefits Of Pfizer/BioNTech COVID-19 Vaccine Outweigh Risks In Children Ages 5 To 11, FDA Review Finds

The Washington Post (10/22, A1, Johnson, McGinley) reported that the Pfizer-BioNTech COVID-19 “vaccine appears poised to become available to children 5 to 11 years old within weeks, after” an FDA “review found the benefits of the shot outweigh the risks i...